BIOTENE ORAL BALANCE GEL (AROMA)

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2019-03-14 for BIOTENE ORAL BALANCE GEL (AROMA) manufactured by Ultradent Products Inc/oratech Llc.

Event Text Entries

[138970940] (b)(4). Report # 3012293198-2019-00020 is associated with (b)(4), biotene oral balance gel (aroma). (previously 1718912-2017-00022) device evaluation ((b)(4)) completed 25 july 2017, product not returned from customer for tube issue
Patient Sequence No: 1, Text Type: N, H10


[138970941] I just came out of the hospital [hospitalization]. I have cataracts in one eye [cataract]. The other eye is shifting now [eye disorder]. I am not feeling good [feeling abnormal]. The product is biotene oral balance gel 1. 5oz (aroma). A 1. 5 oz. Tube only lasted for two days [product complaint]. Case description: this case was reported by a consumer and described the occurrence of cataract in a (b)(6)-year-old female patient who received glycerin (biotene mouth spray (savannah)) oromucosal spray (batch number unk, expiry date unknown) for dry mouth. This case was associated with a product complaint. Co-suspect products included glycerin (biotene oral balance gel (aroma)) gel (batch number unk, expiry date unknown) for dry mouth and sodium fluoride (biotene toothpaste variant not specified (savannah)) toothpaste (batch number unk, expiry date unknown) for dental cleaning. On an unknown date, the patient started biotene mouth spray (savannah), biotene oral balance gel (aroma) and biotene toothpaste variant not specified (savannah) at an unknown dose and frequency. On an unknown date, an unknown time after starting biotene mouth spray (savannah), biotene oral balance gel (aroma) and biotene toothpaste variant not specified (savannah), the patient experienced cataract, eye disorder and product complaint. Biotene mouth spray (savannah) was discontinued (dechallenge was negative). Biotene oral balance gel (aroma) was continued with no change. Biotene toothpaste variant not specified (savannah) was continued with no change. On an unknown date, the outcome of the cataract and eye disorder were not recovered/not resolved and the outcome of the product complaint was unknown. It was unknown if the reporter considered the cataract and eye disorder to be related to biotene mouth spray (savannah), biotene oral balance gel (aroma) and biotene toothpaste variant not specified (savannah). Additional details, the adverse event information was received on 27 june 2017. Consumer reported that, "the product is biotene oral balance gel 1. 5oz (aroma). A 1. 5 oz. Tube only lasted for two days. It usually lasts for two weeks. I use the product two to four times per day. I love this. The product practically saved my life. I have used the product for many, many years. It helps me. It gives me moisture, and i can talk and swallow. There is nothing else like it. I also use the toothpaste. I used to use the spray. I have cataracts in one eye. The other eye is shifting now. I will be seeing the doctor for that. " follow up information was received on 13 july 2017. Consumer used biotene oral balance gel 1. 5oz (aroma) and biotene toothpaste savannah. She stated that she used to use the biotene mouth spray. Consumer stated, "i am not feeling good. I just came out of the hospital. " consumer was (b)(6) years old. She stated that she used biotene oral balance gel 1. 5oz (aroma) two to four times per day. The hospitalization and feeling abnormal event were added to case. Event outcome for hospitalization and feeling abnormal was unknown. The causality for hospitalization and feeling abnormal was unknown. It was unknown if the reporter considered hospitalization and feeling abnormal to be related to biotene mouth spray (savannah), biotene oral balance gel (aroma) and biotene toothpaste variant not specified (savannah). Follow up information was received on 25 july 2017. From quality assurance (qa) department regarding complaint number (b)(4) (issue number) for lot number unknown. The investigation report included that, the product sample was not received. Without the returned product or a valid lot number no investigation can take place. Concern will be re opened and evaluated if the complaint sample was received. This was a low risk, level 1 complaint. Concern can be closed. Expiration date for biotene oral balance gel (aroma) was updated in the case as 31 august 2019.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3012293198-2019-00020
MDR Report Key8420117
Date Received2019-03-14
Date of Report2017-06-27
Date Mfgr Received2017-07-25
Date Added to Maude2019-03-14
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer StreetPO BOX 13398
Manufacturer CityRESEARCH TRIANGLE PARK NC 27709
Manufacturer CountryUS
Manufacturer Postal27709
Manufacturer Phone8888255249
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameBIOTENE ORAL BALANCE GEL (AROMA)
Generic NameORAL GEL
Product CodeLFD
Date Received2019-03-14
Lot NumberUNK
OperatorLAY USER/PATIENT
Device Availability*
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerULTRADENT PRODUCTS INC/ORATECH LLC
Manufacturer AddressSOUTH JORDAN UT US


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Other 2019-03-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.